Koninklijke Philips N.V. (PHG)
| Market Cap | 25.91B +13.3% |
| Revenue (ttm) | 20.34B -1.9% |
| Net Income | 1.12B +160.1% |
| EPS | 1.15 +152.5% |
| Shares Out | 952.02M |
| PE Ratio | 23.16 |
| Forward PE | 14.91 |
| Dividend | $0.82 (3.02%) |
| Ex-Dividend Date | May 13, 2025 |
| Volume | 907,822 |
| Open | 27.38 |
| Previous Close | 27.16 |
| Day's Range | 27.13 - 27.45 |
| 52-Week Range | 21.95 - 33.44 |
| Beta | 0.92 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | May 6, 2026 |
About PHG
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. The company provides diagnostic imaging solutions, includes ultrasound business unit, magnetic resonance imaging, computed tomography, and diagnostic x-ray; Image Guided Therapy, including image guided therapy systems and image guided therapy devices. It also offers monitoring, enterprise informatics, and sleep and respiratory care, as ... [Read more]
News
Royal Philips: Philips shareholders approve all proposals at the AGM 2026
May 8, 2026 Amsterdam, the Netherlands - Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that its shareholders approved all proposals at the Annual Gener...
Philips shareholders approve all proposals at the AGM 2026
May 8, 2026 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that its shareholders approved all proposals at the Annual General ...
Koninklijke Philips Transcript: AGM 2026
The meeting highlighted strong financial progress, adoption of a stable dividend, and ambitious strategic and sustainability goals. Shareholders raised concerns about legal risks, board independence, and quality management, but all proposals and appointments were approved by large majorities.
Philips backs FY26 comparable sales growth view 3%-4.5%
Backs FY26 adjusted EBITDA margin view 12.5%-13%. Backs FY26 free cash flow view EUR 1.3B-1.5B. The company said, “Philips (PHG) 2026 outlook includes currently known information, including tariffs, w...
Q1 2026 Koninklijke Philips NV Earnings Call Transcript
Q1 2026 Koninklijke Philips NV Earnings Call Transcript
PHG Breakdown, Earnings Beat & AI Outlook
CEO of Philips, Roy Jakobs reviews strong earnings highlighting margin expansion despite inflation and a solid start to the year. He notes the company reiterated full-year guidance and remains focused...
Philips Reports Strong Order Intake Despite Uncertain Macro Environment
Koninklijke Philips N.V. (NYSE:PHG) shares were trading higher on Wednesday as the company reported strong order intake and comparable sales growth in its recent first quarter 2026 performance.
From jewelers to health tech, CEOs want tariff refunds as earnings take a hit
Philips and Pandora on Wednesday said they have applied for tariff reimbursement. Several other firms mentioned tariffs as negatively impacting results in a slew of earnings updates.
Philips Sees Strong Sales Growth in Europe
Philips CEO: We will ask Trump administraton for tariff rebate
Philips CEO Roy Jakobs confirms the company will request a rebate on tariffs from the Trump administration, as the Dutch healthcare group says it's seen high growth in order intake, boosted by demand ...
Koninklijke Philips Earnings Call Transcript: Q1 2026
Q1 2026 delivered 6% order intake growth, 4% sales growth, and margin expansion, led by Personal Health and strong North America and Europe performance. Full-year guidance is reiterated, with ongoing cost inflation and macro uncertainty actively managed.
Philips Sees Strong Sales Growth in Europe
Royal Philips posted a drop in first-quarter sales on a nominal basis, even as the health-tech group saw particularly strong growth in Western Europe.
Dutch health-tech group Philips' sales, margins beat estimates on order growth
Dutch healthcare technology group Philips reported first-quarter revenues and margins above market expectations on Wednesday, with order intake growth helped by demand in North America and Europe.
Royal Philips: Philips delivers strong order intake, comparable sales growth and margin expansion in Q1; 2026 outlook reiterated
May 6, 2026Q1 2026 Group performance Comparable order intake growth 6% Group sales of EUR 3.9 billion, reflecting 4% increase in comparable salesIncome from operations increased to EUR 241 millionA...
Philips delivers strong order intake, comparable sales growth and margin expansion in Q1; 2026 outlook reiterated
May 6, 2026 Q1 2026 Group performance Comparable order intake growth 6% Group sales of EUR 3.9 billion, reflecting 4% increase in comparable sales Income from operations increased to EUR 241 million A...
Philips delivers strong order intake, comparable sales growth and margin expansion in Q1; 2026 outlook reiterated
May 6, 2026 Q1 2026 Group performance Comparable order intake growth 6% Group sales of EUR 3.9 billion, reflecting 4% increase in comparable sales Income from operations increased to EUR 241 million A...
Koninklijke Philips NV (PHG) Shares Fall 5.7% -- GF Value Says Still Overvalued
Koninklijke Philips NV (PHG) Shares Fall 5.7% -- GF Value Says Still Overvalued
PHG Makes Notable Cross Below Critical Moving Average
In trading on Thursday, shares of Koninklijke Philips NV (Symbol: PHG) crossed below their 200 day moving average of $27.96, changing hands as low as $27.30 per share. Koninklijke Philips NV shares ar...
Royal Philips: Philips launches new Bridge Plus Occlusion Balloon to help manage rare but life-threatening SVC tears during lead extraction
April 23, 2026 Bridge Plus was designed for rare, life-threatening emergencies to help control bleeding during superior vena cava (SVC) tears, which occur in Bridge Plus allows for rapid response w...
Philips launches new Bridge Plus Occlusion Balloon to help manage rare but life-threatening SVC tears during lead extraction
April 23, 2026 Bridge Plus was designed for rare, life-threatening emergencies to help control bleeding during superior vena cava (SVC) tears, which occur in
Philips (PHG) Secures FDA Clearance for Rembra Scanning Systems
Philips (PHG) Secures FDA Clearance for Rembra Scanning Systems
Philips receives FDA clearance for Rembra platform
Philips (PHG) announced it has received 510 clearance from the FDA for its Rembra platform of scanning systems, including Rembra CT, Rembra RT and Areta RT. The newly cleared systems
Royal Philips: Philips receives FDA 510(k) clearance for its Rembra platform, expanding access to faster, more precise CT imaging across frontline care and cancer treatment planning
April 22, 2026 Clearances for Rembra CT, Rembra RT, and Areta RT enable high-throughput imaging at scale and elevate precision across the cancer care pathway Amsterdam, the Netherlands - Royal Phil...
Philips receives FDA 510(k) clearance for its Rembra platform, expanding access to faster, more precise CT imaging across frontline care and cancer treatment planning
April 22, 2026 Clearances for Rembra CT, Rembra RT, and Areta RT enable high-throughput imaging at scale and elevate precision across the cancer care pathway Amsterdam, the Netherlands – Royal Philips...
Koninklijke Philips NV (PHG) Shares Surge 3.7% -- What GF Score of 79 Tells Investors
Koninklijke Philips NV (PHG) Shares Surge 3.7% -- What GF Score of 79 Tells Investors